Pre-treatment prediction of response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis: the UDCA Response Score

BACKGROUND: Current guidelines advocate a step-wise approach to disease-modifying treatment of primary biliary cholangitis (PBC): all patients begin treatment with ursodeoxycholic acid (UDCA) monotherapy – and those with inadequate biochemical response to UDCA are subsequently considered for second-...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Lancet Gastroenterol Hepatol
Auteurs principaux: Carbone, M, Nardi, A, Flack, S, Carpino, G, Varvaropoulou, N, Gavrila, C, Spicer, A, Badrock, J, Bernuzzi, F, Cardinale, V, Ainsworth, HF, Heneghan, MA, Thorburn, D, Bathgate, A, Jones, R, Neuberger, JM, Battezzati, PM, Zuin, M, Taylor-Robinson, S, Donato, M, Kirby, J, Mitchell-Thain, R, Floreani, A, Sampaziotis, F, Muratori, L, Alvaro, D, Marzioni, M, Miele, L, Marra, F, Giannini, E, Gaudio, E, Ronca, V, Bonato, G, Cristoferi, L, Malinverno, F, Gerussi, A, Stocken, DD, Cordell, HJ, Hirschfield, GM, Alexander, GJ, Sandford, RN, Jones, DE, Invernizzi, P, Mells, GF
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6962055/
https://ncbi.nlm.nih.gov/pubmed/30017646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(18)30163-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires